Management of herpes simplex virus infections

Current Paediatrics

Volumn 14, Issue 2, 2004, Pages 131-136

  Jones, Cheryl A ^a,b   Isaacs, David ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Antiviral agents; Childhood; Herpes simplex virus; Management

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; FOSCARNET; IMMUNOGLOBULIN M; NON PRESCRIPTION DRUG; PENCICLOVIR; VALACICLOVIR; VIDARABINE; VIRUS DNA;

BLOOD CULTURE; CEREBROSPINAL FLUID ANALYSIS; CESAREAN SECTION; CHILD HEALTH CARE; CHILD SEXUAL ABUSE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; GENITAL HERPES; HERPES LABIALIS; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RISK; MEDICAL DECISION MAKING; NEUTROPENIA; NEWBORN INFECTION; NEWBORN MORTALITY; NONHUMAN; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROGNOSIS; RECURRENT INFECTION; SURVIVAL RATE; SYMPTOM; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 1542374083     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2003.11.013     Document Type: Conference Paper

References (10)

1. Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980;66:495-501.
2. Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:444-53.
3. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
4. Nyquist AC, Rotbart HA, Cotton M, et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr 1994;124:967-71.
5. Oram RJ, Marcellino D, Strauss D, et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis 2000;181:1458-61.
6. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
7. Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase i/ii trial. Pediatr Infect Dis J 1996;15:247-54.
8. Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ 1997;314:1800-3.
9. Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years experience with aciclovir. J Infect Dis 2002;186:S40.
10. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986;314:144-9.